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Streptococcus agalactiae (Group B Streptococcus, GBS) is an important human pathogen
that colonizes the urogenital and/or the lower gastro-intestinal tract of up to 40% of
healthy women of reproductive age and is a leading cause of sepsis and meningitis
in the neonates. GBS can also infect the elderly and immuno-compromised adults,
and is responsible for mastitis in bovines. Like other Gram-positive bacteria, GBS can
form biofilm-like three-dimensional structures that could enhance its ability to colonize
and persist in the host. Biofilm formation by GBS has been investigated in vitro and
appears tightly controlled by environmental conditions. Several adhesins have been shown
to play a role in the formation of GBS biofilm-like structures, among which are the
protein components of pili protruding outside the bacterial surface. Remarkably, antibodies
directed against pilus proteins can prevent the formation of biofilms. The implications of
biofilm formation in the context of GBS asymptomatic colonization and dissemination to
cause invasive disease remain to be investigated in detail.
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INTRODUCTION
The beta-hemolytic Gram-positive Streptococcus agalactiae
(Group B Streptococcus, GBS) is often encountered in the
gastro-intestinal and the genital tract of healthy women as
part of the normal flora. From this site, the bacteria can reach
the newborn through the birth canal and cause sepsis and/or
meningitis (Gibbs et al., 2004; Dando et al., 2014). GBS is also
an important cause of morbidity and mortality in the elderly
and in immuno-compromised adults. Primary manifestations
of adult GBS disease include bacteremia, skin and soft tissue
infections, pneumonia, osteomyelitis and urinary tract infections
(Edwards et al., 2005; Skoff et al., 2009). GBS can also colonize
the mammary gland of ruminants, where it is able to survive
for long periods causing clinical and sub-clinical mastitis (Keefe,
1997).
GBS colonization and infection of target tissues requires the
capacity of these bacteria to adhere and to persist in mucosal
epithelial surfaces. In this habitat, the formation of biofilm-like
communities could facilitate microbial survival and proliferation
by enhancing resistance to host defenses and nutrient deprivation.
The present review summarizes recent studies investigating the
capacity of GBS to form biofilm-like structures in vitro, how this
mode of growth is affected by environmental conditions, and the
contribution of adhesin virulence factors.
EXPERIMENTAL EVIDENCE OF GBS BIOFILM FORMATION
AND INFLUENCE OF ENVIRONMENTAL CONDITIONS
Initial evidence suggesting that GBS could be implicated in
the formation of biofilms came from studies by Donlan and
Costerton where GBS bacteria were found on intrauterine
devices in association with other known biofilm formers such
as Staphylococcus aureus and Staphylococcus epidermidis (Donlan
and Costerton, 2002).
Macroscopic assays were set up to investigate the biofilm
forming capacity of GBS strains belonging to different lineages
(Rinaudo et al., 2010). According to these type of assay, bacte-
ria are cultured under static conditions in the wells of plastic
tissue culture plates and, after several washes, microbial three-
dimensional structures are stained with crystal violet or similar
compounds (O’Toole et al., 2000).
More restrictive experimental methods have recently been
set up to better discriminate between GBS weak and strong
biofilm formers. One of these approaches mimics fluid circula-
tion in the host by using flow conditions in laminar chamber
systems (Konto-Ghiorghi et al., 2009). An alternative multiwell-
based protocol is based on plate incubation under shaking and
removal of non-attached bacteria by extensive washing, followed
by replacement of the growth medium (D’Urzo et al., 2014).
Environmental conditions are known to strongly influence the
capacity to form biofilm by many bacterial species (Froeliger and
Fives-Taylor, 2001; Moscoso et al., 2006; Manetti et al., 2007).
Several studies have investigated GBS in vitro biofilm formation
using one of the above described methods and different growth
media, with contrasting results. For instance, Kaur et al. (2009),
Borges et al. (2012), and Yang et al. (2012) investigated biofilm
production under neutral and acidic pH conditions. They found
larger biofilm amounts at pH 6.5 compared to pH 4.2, prob-
ably due to poor bacterial growth at low pH. By contrast, Ho
et al. (2013) found that low pH induced biofilm formation in
nutrient-limited chemically defined medium (M9YE) and not in
rich media like Todd-Hewitt Broth (THB). Konto-Ghiorghi et al.
(2009) reported that a uniform biofilm was produced only on
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Luria Broth and RPMI 1640 supplemented with 1% glucose. The
need for glucose for GBS biofilm formation was confirmed by
Rinaudo et al. who also demonstrated that this sugar does not
affect planktonic bacterial growth (Rinaudo et al., 2010). Previous
studies had shown that in the GBS related species Streptococcus
pyogenes the glucose biofilm enhancing effect was the direct result
of acidification due to metabolic production of organic acids
(Manetti et al., 2010). Evidence that acidic pH and not glu-
cose concentration was the environmental signal driving GBS
biofilm formation in vitro was obtained by D’Urzo et al. (2014).
The authors tested a wide panel of strains in both buffered or
non-buffered nutrient-rich (THB) and nutrient-limited (RPMI)
media, in the presence or absence of glucose. Strong biofilm for-
mation was observed only in glucose-containing non-buffered
media and in low pH media even in the absence of glucose. In
an in vivo setting, exposure of GBS to the acidic milieu of the
vagina could be the signal sensed by the bacteria to grow in a ses-
sile mode in this site. In this context, temporal shifts in GBS loads
were recently observed in a mouse model of vaginal coloniza-
tion (Carey et al., 2014), and have also been reported in humans
(Hansen et al., 2004). It is tempting to speculate that pH varia-
tions and consequently GBS biofilm formation on epithelial cells
could affect GBS carriage fluctuations.
Therefore, the discrepancies between the different studies in
the observed capacity of GBS strains to form biofilm-like struc-
tures in vitro can possibly be explained by the use of different
types of assays and growth conditions.
CONTRIBUTION OF PILI AND OTHER SURFACE VIRULENCE
FACTORS TO GBS BIOFILM FORMATION
Long filamentous structures protruding from the surface of
Gram-positive bacteria were discovered in the last decade (Ton-
That and Schneewind, 2004; Soriani and Telford, 2010). These
structures resemble the pili found in Gram-negative bacteria,
although in Gram-positives pilus protein components are linked
by covalent bonds.
Pili in S. agalactiae were discovered during screening of mul-
tiple genomes for surface-exposed protein antigens as possible
vaccine targets (Lauer et al., 2005). By SDS-PAGE, the pilus
polymers appeared as a ladder of bands ranging from 150 kDa
to beyond the resolution of the gels, while immune electron
microscopy revealed long appendages protruding outside the
capsule that covers the bacterial surface (Figure 1). The genes
encoding the GBS pilus machinery are clustered in three related
genomic islands (Islands PI-1, -2a, and -2b) located in two sepa-
rate loci flanked by direct repeats and conserved genes. All islands
contain three genes encoding the pilus components, i.e., one
backbone protein essential for pilus assembly (BP) and two acces-
sory proteins (AP1 and AP2), plus two genes encoding sortase
enzymes catalyzing the covalent linkage of the pilus proteins into
long polymers (Dramsi et al., 2006; Rosini et al., 2006). The pilus
proteins of PI-1 and PI-2b differ by very few amino acids, while
PI-2a is more variable with seven alleles described both for the BP
and the AP1 presenting sequence identities between 48–98% for
BP and 87–98% for AP2. Remarkably, mouse immunization with
BP-1, BP-2b, and AP1-2a conferred protection against infection
with a large panel of virulent strains, and at least one of the three
FIGURE 1 | Pilus Island-2a. Immunogold transmission electron microscopy
of GBS 515 grown to exponential phase. Bacteria were incubated with
polyclonal sera raised against the corresponding pilus 2a backbone variant
obtained as recombinant protein, and labeled with secondary antibodies
conjugated with 10 nm gold nanoparticles.
islands is present in all GBS (Margarit et al., 2009; Madzivhandila
et al., 2011; Martins et al., 2013).
The discovery of pili in Gram-positive pathogens raised the
question on the possible role of these highly surface-exposed
structures in host colonization and infection. Pioneering evidence
for their involvement in cell adhesion and biofilm formation was
obtained in S. pyogenes (Manetti et al., 2007).
Studies using GBS isogenic mutants lacking pilus 2a compo-
nents or the sortase enzymes responsible for pilus polymerization
and cell wall attachment, indicated a role of pili in host cell contact
and in the formation of multi colony three-dimensional struc-
tures on abiotic surfaces (Konto-Ghiorghi et al., 2009; Rinaudo
et al., 2010). These biofilm-like structures were also analyzed by
confocal laser scanning microscopy where the wild-type GBS515
strain bearing pilus variant 2a and an isogenic mutant unable
to assemble pili, were seeded on glass polylysine-coated cover-
slips and stained with a fluorescent dye. As shown in Figure 2,
the wild-type strain formed structured multilayered aggregates of
surface-adherent bacteria resembling a mature biofilm, while the
deletion mutant did not.
Remarkably, antibodies directed against the backbone of pilus
2a and its main ancillary protein inhibited the formation of these
biofilm-like structures in a dose dependent manner, while anti-
bodies against the small ancillary protein located at the pilus base
near the cell wall, did not show any effect (Rinaudo et al., 2010).
The same study investigated biofilm formation by 289 GBS clin-
ical isolates using the above described crystal violet assay under
static conditions. A correlation between the high surface exposure
of pilus 2a and the biofilm formation phenotype was observed.
In the more recent study by D’Urzo et al., the formation of
biofilm-like structures in vitro by 389 GBS isolates was inves-
tigated under more stringent conditions to better discriminate
between weak and strong biofilm formers (see above). Also in
this case, a high variability among strains was observed both in
pilus expression and in the capacity to form biofilms, even when
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FIGURE 2 | Pilus Island-2a involvement in the formation of biofilms
in vitro. Confocal scanning laser microscopy micrographs of biofilm
development by GBS 515 (A) and its mutant derivative containing an in-frame
deletion in the pilus backbone gene (Rosini et al., 2006) (B). Bacteria were
grown on glass coverslips under static conditions at 37◦C for 72 h, fixed and
stained with SYTO-9 prior to confocal analysis (magnification 60x).
they belonged to the same serotype orMLST phylogenetic lineage.
A subset of serotype III strains belonging to the hyper virulent
lineage ST-17 harboring both pilus 1 and 2b was shown to form
stronger biofilms than all other tested strains, particularly at low
pH (D’Urzo et al., 2014). Importantly, ST-17 strains are the most
frequent cause of late-onset neonatal infections (Tazi et al., 2010).
The proteins responsible for the higher capacity of this ST-17 sub-
set of strains to form biofilms have not yet been identified, and
could be possible targets to prevent colonization/disease of this
hypervirulent lineage.
Park et al. investigated the phenotype of the CsrRS two-
component regulatory system knockout, and showed an increase
capacity of CsrRS mutant bacteria to adhere to host cells and
to form biofilm-like structures on plate (Park et al., 2012). This
regulatory effect of CsrRS on bacterial adherence and biofilm
formation correlated with the expression of multiple surface
adhesins but not of Pilus 1, excluding a role of this pilus vari-
ant in biofilm formation in the investigated isolate. The same and
other authors identified BsaB/FbsC as a protein adhesin involved
in biofilm formation and regulated by the CsrRS system (Buscetta
et al., 2014; Jiang andWessels, 2014); different from the pilus pro-
teins, FbsC expression appeared slightly downregulated in a CsRS
dependent manner at acidic versus neutral pH.
CONCLUSIONS
Similar to other Gram-positive pathogens colonizing the human
host, Group B Streptococcus can form multicellular communities
that are expected to facilitate its persistence under environmental
stress conditions. A number of in vitro studies have demonstrated
that GBS forms biofilm-like structures on abiotic surfaces. Yet,
the presence in these structures of the extracellular matrix typi-
cal of bacterial biofilms has not been investigated in this species.
Additional studies are also needed to confirm the relevance of
biofilm formation in vivo. If this would be the case, the involved
virulence factors could constitute new therapeutic and preventive
targets against this important human pathogen.
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